We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Invitrogen Introduces Dynachip™ HLA Antibody Analysis System

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Invitrogen Corporation has introduced its DynaChip™ HLA Antibody Analysis system.

DynaChip™ technology will utilize an automated microarray platform to detect antibody reaction to specific HLA antigens. 

The DynaChip™ technology is developed as a result of collaboration between German array developer Clondiag, a unit of Inverness Medical Innovations, Inc., and Invitrogen.

The product is designed to perform upto 96 tests at the same time in a fully automated manner, with each test including an array of proteins.

The system includes software that can allow for rapid analysis of results. The DynaChip™ system is currently available in Europe under a CE mark and is available for ‘research use only’ in the United States.

It is in the process of obtaining FDA 510K clearance in the United States.